|本期目录/Table of Contents|

[1]朱芳萱,卢锋,李卫,等.联合检测同型半胱氨酸与脂蛋白a对高血压患者动脉粥样硬化的预测意义[J].国际心血管病杂志,2023,05:322-325.
 ZHU FangxuanLU FengLI WeiYANG Jianrong..Combined homocysteine and lipoprotein(a) for predicting atherosclerosis in hypertensive patients[J].International Journal of Cardiovascular Disease,2023,05:322-325.
点击复制

联合检测同型半胱氨酸与脂蛋白a对高血压患者动脉粥样硬化的预测意义(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年05期
页码:
322-325
栏目:
出版日期:
2023-09-01

文章信息/Info

Title:
Combined homocysteine and lipoprotein(a) for predicting atherosclerosis in hypertensive patients?
作者:
朱芳萱卢锋李卫杨建荣
530016 南宁,广西壮族自治区人民医院(广西医学科学院)健康管理中心(朱芳萱,李卫,杨建荣),老年心血管病科(卢锋)
Author(s):
ZHU Fangxuan12LU Feng324LI Wei12YANG Jianrong1.12
1.Department of HealthManagement Center, People'2.s Hospital of Guangxi Zhuang Autonomous Region, Nanning? 530016;3.Department of Geriatric Cardiovascular Medicine, People'4.s Hospital of Guangxi Zhuang Autonomous Region, Nanning? 530016, China
关键词:
高血压动脉粥样硬化同型半胱氨酸脂蛋白a
Keywords:
Hypertension Carotid atherosclerosis Homocysteine Lipoprotein (a)
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.05.014
文献标识码:
-
摘要:
目的:探讨联合检测高血压患者同型半胱氨酸(Hcy)、脂蛋白a[Lp(a)]对动脉粥样硬化(AS)风险的预测价值。方法:分别采用酶循环法和免疫比浊法检测326例高血压AS患者(AS组)和324例高血压非AS患者(非AS组)血清中Hcy、Lp(a)水平,采用二元logistic回归分析高血压患者AS的影响因素。通过受试者工作特征曲线(ROC曲线)分析血清Hcy和Lp(a)联合检测对AS风险的预测价值。结果:AS组血浆Hcy、Lp(a)、低密度脂蛋白胆固醇(LDL-C)水平明显高于非AS组(P均<0.05)
Abstract:
Objective? To investigate the performance of combined homocysteine (Hcy) and lipoprotein(a) [Lp(a)] for assessing atherosclerosis (AS) risk in hypertensive patients.? Methods? Serum levels of Hcy and Lp(a) were measured by enzyme cycling and immunoturbi

参考文献/References

-

备注/Memo

备注/Memo:
基金项目:广西壮族自治区卫生健康委员会自筹经费科研课题(Z20210204);广西科技重大专项(桂科AA22096018)
通信作者:卢锋, E-mail:2127655@qq.com
更新日期/Last Update: 2023-09-01